Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis.
D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D000707:Anaphylaxis; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001572:Benzofurans / Q000494:pharmacology*; D001794:Blood Pressure; D004155:Diphenhydramine / Q000494:pharmacology*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D017705:Lignans; D008168:Lung / Q000187:drug effects / Q000503:physiopathology*; D008297:Male; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000502:physiology*; D010976:Platelet Count; D011720:Pyrazoles / Q000494:pharmacology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001572:Benzofurans; D017705:Lignans; D010972:Platelet Activating Factor; D011720:Pyrazoles; D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D004155:Diphenhydramine; C044540:kadsurenone